Learn how libido, morning erections and erectile function differ, and why assessment considers hormones alongside cardiovascular and other health factors.
How do libido, morning erections, and erectile function differ? Libido is sexual desire, morning erections are erections noticed on waking, and erectile function describes the ability to get and maintain an erection during sexual activity.
This article is for informational purposes only and is not medical advice. Individual symptoms and decisions about testing or treatment belong with a qualified clinician.
Wanting sex and having an erection are different aspects of sexual health. The European Association of Urology (EAU) recommends asking about sexual desire separately from the firmness and duration of erections. Its guidance also distinguishes morning erections from those that occur during sexual stimulation.
These distinctions help clarify what has actually changed:
The EAU also asks clinicians to consider arousal, ejaculation and orgasm. A general statement such as “my sexual function has changed” leaves several different questions unanswered.
Understanding the difference between sexual interest and erection quality gives those questions clearer language. It allows a consultation to address the specific concern rather than treating every sexual change as interchangeable.
Morning erections are useful information within a sexual history. The EAU recommends recording their firmness and duration alongside the same details about sexually stimulated erections. Simply noting whether they occur leaves out part of that assessment.
Their presence or absence alone does not diagnose testosterone deficiency or provide a definitive verdict on erectile health. Normal morning erections also do not prove that difficulties during sexual activity have a psychological cause.
The EAU discusses a more formal investigation called nocturnal penile tumescence and rigidity testing. This measures nighttime erections and may help distinguish physical from psychological contributors to erectile dysfunction.
However, the guideline identifies limitations in how nighttime findings relate to erections during sex. Age and situational factors may affect results. Depression and sleep-related factors may also influence interpretation, which limits the test's routine diagnostic usefulness.
For a clinical conversation, the useful information is the pattern being noticed: whether erections occur on waking and how firm or lasting they seem. That observation belongs alongside the account of erections during sexual activity rather than replacing it.
The EAU defines erectile dysfunction, or ED, as a persistent inability to attain or maintain an erection sufficient for satisfactory sexual performance. The emphasis is on an ongoing difficulty rather than treating every weaker erection as a diagnosis.
The distinction between attaining and maintaining an erection is also useful. Difficulty getting an erection and difficulty keeping one are both relevant to the history. A description of either is more informative than the broad statement that erections are “not normal.”
ED describes an erection problem, not necessarily reduced sexual interest. A clinician therefore needs to ask about desire even when erection difficulty is the main concern.
The EAU further describes ED as a symptom rather than a disease in itself. Persistent or recurring difficulty is a reason to assess possible underlying contributors, including health conditions that may not previously have been evaluated.
Testosterone has a place in the assessment because the EAU recognizes hormonal causes of ED, including hypogonadism. It recommends screening men who present with ED for possible testosterone deficiency. Relevant symptoms include reduced libido and reduced energy or fatigue.
The guideline recommends early-morning total testosterone testing in a fasting state as part of the evaluation. That recommendation places hormone testing within a broader medical assessment, alongside other investigations and the sexual history.
The EAU also lists vascular and neurological causes of ED. Structural problems, medication effects and psychological contributors belong in the same assessment. Causes commonly overlap, so the clinical task is to consider how the findings fit together.
On treatment, the EAU says testosterone therapy may be considered when low or low-normal testosterone accompanies specified sexual problems. These include problems with desire or erectile function and concerns about sexual satisfaction. Treatment decisions require clinical interpretation of those findings and any coexisting causes.
For readers researching symptoms, placing sexual changes in their hormonal context is more useful than starting with an assumed treatment.
The EAU says ED should be considered a precursor of cardiovascular disease. It also reports that more severe and longer-standing ED is associated with greater cardiovascular risk. This warrants assessment rather than proving that an individual man already has cardiovascular disease.
The guideline identifies several relevant risk factors:
This is why an assessment of erections may include questions that seem broader than sexual function. The EAU recommends considering glucose and lipid measurements as part of identifying potentially reversible risk factors and coexisting conditions.
It also recommends checking blood pressure and heart rate when they have not been assessed recently. BMI or waist circumference can contribute to evaluating relevant health conditions.
The connection between erectile function and wider cardiovascular or metabolic health helps explain this approach. The purpose is to assess the person as a whole rather than investigate testosterone in isolation.
The EAU includes medication-related causes in its assessment of ED. Examples include some blood-pressure medicines and some antidepressants. It also lists antipsychotics and antiandrogens among possible contributors.
These categories do not establish that a particular prescription caused an individual's symptoms. They identify areas for a clinician to review alongside the rest of the history. Men should not stop prescribed medication on their own because they suspect a connection with erection changes.
Psychological and relationship factors also deserve direct attention. The EAU identifies depression, anxiety and stress-related mood changes as relevant to erectile difficulties. Relationship factors form another part of the assessment.
These questions are not a dismissal of a physical concern. They reflect the guideline's recognition that ED may have mixed causes. A review can consider hormonal or vascular findings while also addressing medication and psychological context.
Describing these areas separately helps keep the discussion specific. It avoids replacing an unexplained symptom with an assumption about either hormones or mental health.
The EAU's recommended history provides a useful framework for an appointment. The aim is to describe the experience clearly, not to decide its cause beforehand.
Relevant information includes:
These are separate descriptions that a clinician can consider together. There is no need to make the experiences fit a single explanation before discussing them.
The guideline also supports asking about other sexual domains, including arousal and orgasm. If several aspects have changed, identifying each one gives the consultation a clearer starting point than using “low testosterone symptoms” as an overall label.
The EAU recommends a comprehensive medical and sexual history, a focused physical examination and relevant laboratory evaluation for men with ED. The process brings the separate sexual signals into the context of overall health.
The recommended laboratory assessment includes glucose, a lipid profile and total testosterone. Testosterone measurement is specified as early morning and fasting. These investigations address different possible contributors rather than offering competing explanations from which a patient must choose.
The physical assessment adds another layer of information. Blood pressure and heart rate may need checking if they have not been assessed recently. BMI or waist circumference helps assess relevant coexisting conditions.
A physician or endocrinologist can then interpret the symptom history alongside examination and laboratory findings. Personal testing and treatment decisions belong within that clinical discussion.
The practical message is to describe desire and both types of erections separately, then assess them together. That approach keeps hormonal questions in view while allowing cardiovascular and metabolic health to receive attention. Medication and psychological factors remain part of the same discussion.
How might future research refine the way clinicians combine these distinct sexual signals with hormone results and cardiovascular risk assessment?
Sexual changes call for explanations that account for more than testosterone, and Testostra keeps that wider context within its hormone health education. For men uncertain about reduced desire or changing erections, its evidence-led coverage connects symptom questions to possible causes without assigning a personal diagnosis.
Testostra follows testosterone research, clinical guidance and emerging evidence without turning general information into personal treatment advice.
Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.
Contact Testostra